Outlook Therapeutics, Inc 10-Q for FY2025 Q3
Outlook Therapeutics, Inc. (OTLK)
10-Q
2025-08-14
For: 2025-06-30
View Original
Added on
April 10, 2026
About this 10-Q
Outlook Therapeutics, Inc filed this 10-Q on August 14, 2025, covering the quarter ended June 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.51M
- Net loss
- $20.15M
- compared with net income of $44.41M a year earlier
- Diluted EPS
- -$0.55
- compared with -$0.89 a year earlier